OTTAWA, May 29, 2015 /CNW/ -
The issue:
Health Canada is warning consumers that an unauthorized drug, "Stiff Rock" promoted for male sexual performance enhancement was seized from Boutique Érotique 5ieme avenue (also known as Boutique Érotique Liberté), 507 Gande-Île., Valleyfield, QC after Health Canada testing confirmed that the product contained drug ingredients: sildenafil; aminotadalafil; and hydroxythiohomosildenafil.
Products affected:
"Stiff Rock", available in one tablet per blisterpack, LOT: 100237, EXP: 2016-04-01
Who is affected:
Consumers who have bought or used "Stiff Rock", particularly those with heart conditions.
What consumers should do
What Health Canada is doing:
Following a seizure of a shipment of "Stiff Rock" at the border, Departmental testing identified sildenafil, aminotadalafil and hydroxythiohomosildenafil. As a result, Health Canada seized additional units of "Stiff Rock" from the importer, Boutique Érotique 5ieme avenue (also known as Boutique Érotique Liberté). Should additional lots be identified, Health Canada will take appropriate action and inform Canadians.
Background:
Products containing sildenafil should only be used under the supervision of a healthcare practitioner. Sildenafil should never be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems including high blood pressure, a history of heart attack, stroke, abnormal heart beat or chest pain, are at higher risk of cardiovascular side effects. Other possible side effects of using sildenafil include headache, facial flushing, indigestion, dizziness, abnormal vision and hearing loss.
Hydroxythiohomosildenafil is a substance similar to sildenafil, and may pose similar health risks.
Aminotadalafil is a substance similar to tadalafil, a prescription drug used to treat erectile dysfunction and may pose similar health risks.
How to report side effects to health products to Health Canada:
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
Également disponible en français
SOURCE Health Canada
PDF available at: http://stream1.newswire.ca/media/2015/05/29/20150529_C6167_PDF_EN_17279.pdf
Media Enquiries: Health Canada, (613) 957-2983; Public Enquiries: (613) 957-2991, 1-866 225-0709
Share this article